The Zambia Childhood Cancer Foundation, ZACCAF- has expressed concern over high cost of sickle cell medication in the country.
ZACCAF Chairperson, Charity Pikiti, says pharmaceutical companies have been exaggerating prices of sickle cell drugs.
Ms Pikiti say “hydroxy urea” a drug for sickle cell patients is being sold between 9 and 15 kwacha per capsule which is not affordable for most people with the condition.
She was speaking in Lusaka in an interview to mark the Sickle Cell day which falls today.
She said ZACCAF will not tolerate pharmaceutical companies capitalising on the condition of sickle cell children to make huge profits.